chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive for Covid infection; loss of taste; eyeballs started to hurt; stomach not functioning; loss of appetite; lack of sleep; chills; Body ache; feverish feeling/accelerated after vaccination; very minor cough, accelerated after vaccination; felt messy for a week; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (positive for Covid infection), AGEUSIA (loss of taste), EYE PAIN (eyeballs started to hurt), GASTRIC DISORDER (stomach not functioning) and DECREASED APPETITE (loss of appetite) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced FEELING ABNORMAL (felt messy for a week) and COUGH (very minor cough, accelerated after vaccination). On an unknown date, the patient experienced COVID-19 (positive for Covid infection), AGEUSIA (loss of taste), EYE PAIN (eyeballs started to hurt), GASTRIC DISORDER (stomach not functioning), DECREASED APPETITE (loss of appetite), INSOMNIA (lack of sleep), CHILLS (chills), MYALGIA (Body ache) and PYREXIA (feverish feeling/accelerated after vaccination). At the time of the report, COVID-19 (positive for Covid infection), AGEUSIA (loss of taste), EYE PAIN (eyeballs started to hurt), GASTRIC DISORDER (stomach not functioning), DECREASED APPETITE (loss of appetite), INSOMNIA (lack of sleep), CHILLS (chills), MYALGIA (Body ache) and PYREXIA (feverish feeling/accelerated after vaccination) outcome was unknown, FEELING ABNORMAL (felt messy for a week) had resolved and COUGH (very minor cough, accelerated after vaccination) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. Treatment medication included Benadryl and Tylenol.
sore arm; 1st two doses made her sick for a day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and ILLNESS (1st two doses made her sick for a day) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Dialysis since an unknown date. Concurrent medical conditions included Diabetic and Cataract (Cataract in one eye).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and ILLNESS (1st two doses made her sick for a day). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown and ILLNESS (1st two doses made her sick for a day) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-416207, MOD-2021-416208 (Patient Link).
Had severe redness and itch on the arm where received shot and for 2 1/2 weeks. On third or fourth day I started having back pains and pain on the arm (right) where administered. The pains worsened and continued for four days - pains shooting down my legs - swelling of the knees I realized it was an allergic reaction and started taking BENADRYL. The BENADRYL reversed the reaction and I started feeling better - It was like the sciatic nerve had been affected.
Information has been received from a physician concerning a 5 year old male who on 04-Sep-2001, was vaccinated with a dose of Varivax. Subsequently, on 17-May-2006 the patient experienced breakthrough varicella rash. Unspecified medical attention was sought. No further information available. There was no product quality complaint involved. Additional information received indicated that there was no further information available. No additional information is expected.
Narrative:  Patient is 82 years old with cardiovascular disease and fell when bending over to pick something up. Therefore, it is not clear if fall was caused by these risk factors or by the vaccine. However, he had complained of weakness prior to this episode.
Arm very sore, hurt several days; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 11-AUG-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingles vaccine and it hurt (arm sore) for several days but better than shingles. The patient stated that if you did like him/her their arm would be very sore tomorrow. He/she advised to take Tylenol tonight. Additional Supportive Information: Follow-up would not possible as no contact details were available.
This spontaneous report was received from a medical assistant referring a patient of unknown age or gender. The patient's concurrent conditions, medical history or concomitant medication were not provided. On 12-JUL-2012 and on 27-JUL-2013, the patient was vaccinated with GARDASIL 9 (strength, dose, route of administration, lot number and expiration date were not reported) both for prophylaxis, respectively. On 30-MAR-2017, the patient was in the office for her third dose of GARDASIL 9. No adverse symptoms reported. Additional information has been requested.
redness at the injection site; swollen lymph nodes;  A spontaneous report was received from a Healthcare Professional concerning a 38 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, redness at the injection site, swollen lymph nodes. The patient's medical history was not provided. No relevant concomitant medications were reported. On 26 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot batch: 030L20A) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the events, redness at the injection site . On an unknown date, the patient experienced the events, swollen lymph nodes. Treatment details included Benadryl and Tylenol Action taken with mRNA-1273 in response to the events, redness at the injection site, swollen lymph nodes was not reported.   On an unknown date the outcome of events include, redness at the injection site, swollen lymph nodes was not reported.
Pfizer-BioNTech COVID-19 Vaccine EUA: The evening of and the next day after receiving  vaccine patient developed arm discomfort, facial swelling, and extremity rashes that resolved within 24 hours. Patient took acetaminophen for arm pain and diphenhydramine every twelve hours for swelling. During clinic visit to refill anti-hypertensive medications two days after vaccination patient reports symptoms resolved. Vitals within normal ranges except blood pressure elevated. Patient discharged from clinic visit to home stable.
w/in a few days of the vax pt began w/URI sx & a choking cough w/inspiratory noise; pt required hospitalization x 5 days;
lump nods under arm swollen and sore left side of chest sore  for 3 weeks
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: Patient says after receiving the vaccine he received a lump on arm which resulted in pus coming out of the wound. Patient said it was itching and swollen and led to open wound that was leaking pus. After observing patient's arm, I think it was not due to incorrect administration but skin reaction. Also unsure if patient even received vaccination at that spot.
pain in arm; a fever of 103 degrees; received 1st dose of Trumenba in 2018/nurse reported the incident late in the afternoon on 17Sep2019 and has requested information regarding the completion of the Trumenba series; This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA; lot number and expiration date were unknown), via an unspecified route of administration on 2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The nurse reported that the patient received the 1st dose of meningococcal group b rlp2086 in 2018, and within 48 hours the patient complained of pain in arm and reported a fever of 103 degrees to the office. The nurse reported the incident late in the afternoon on 17Sep2019 and has requested information regarding the completion of the meningococcal group b rlp2086 series. The nurse was asking if it was safe and recommended to complete the series with this patient following the adverse events that occurred following the first dose in 2018. The outcome of the events was unknown.  Information on the batch/lot number has been requested.
Moderna 1/12/21 and 2/10/21. Positive on 1/7/22
Felt tired; Patient felt ringing in her ears; Left arm injection site arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Patient felt ringing in her ears), VACCINATION SITE PAIN (Left arm injection site arm hurt) and FATIGUE (Felt tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced TINNITUS (Patient felt ringing in her ears) and VACCINATION SITE PAIN (Left arm injection site arm hurt). On an unknown date, the patient experienced FATIGUE (Felt tired). At the time of the report, TINNITUS (Patient felt ringing in her ears), VACCINATION SITE PAIN (Left arm injection site arm hurt) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information were provided.   This case was linked to MOD-2021-333554 (Patient Link).
Hep A & B vaccines-fever 101 then rose to 103.  Administered 3 aspirin and fever went away.  Dec 29-same day as shots.
REALLY BAD SIDE EFFECTS; UNCONTROLLABLE SHAKING/SHIVERING; ACHED ALL OVER; RIBS ACHE; COULDN'T WALK; CHILLS; HEADACHE; NO ENERGY/LACK OF ENERGY; FEVER; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient was not using any medication, patient was very healthy, patient was very sensitive. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 27-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 28-APR-2021, the patient experienced really bad side effects. On 28-APR-2021, the patient experienced chills. On 28-APR-2021, the patient experienced uncontrollable shaking/shivering. On 28-APR-2021, the patient experienced headache. On 28-APR-2021, the patient experienced ached all over. On 28-APR-2021, the patient experienced no energy/lack of energy. On 28-APR-2021, the patient experienced ribs ache. On 28-APR-2021, the patient experienced couldn't walk. On 28-APR-2021, the patient experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from really bad side effects, chills, uncontrollable shaking/shivering, couldn't walk, and fever on 28-APR-2021, headache on 29-APR-2021, and ached all over, no energy/lack of energy, and ribs ache on 01-MAY-2021. This report was non-serious.
ADMINISTERED EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 46 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 2052A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 25-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-SEP-2021, the patient experienced administered expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administered expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210958564, 20210958534, 20210958784 and 20210959706.
Patient was given the wrong vaccine.  Patient was suppose to be given TDAP and was given Prevnar 13 instead.  Patient is 27 plus weeks pregnant.  Patient has not had any reaction to the shot at this point and is aware that the wrong immunization was given.  CDC was also notified and did not find any reason that there should be any reaction.
Localized reaction @ site of injection Area of 4X5" around site, red, hot swollen Pt not able to lift arm X3 days. Is able to here. Treated with ASA, Ibuprofen, BENADRYL & warm packs to area. Area slowly improved. Does not feel he needs to see MD @ this time. Ctr RN
Focus=Full body; Activity=Tonic/clonic; Color=Pt became pale; Time=30 second seizure activity; Supplemental Info=Chicken pox vaccine received 9/1/11 pt developed lethargy x24 hrs later with nausea/vomit/diarrhea x36 hrs.
developing itchiness, a little redness at the left breast a little below the waistline, itching in the scalp and the right eye; developing itchiness, a little redness at the left breast a little below the waistline, itching in the scalp and the right eye; itching in the scalp and the right eye; This is a spontaneous report from a contactable consumer (patient).   An 80-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3302 and Expiration date: unknown), via an unknown route of administration, administered in left arm close to shoulder on 01Feb2021 around 02:30 (at the age of 80-years-old) as dose 1, single for covid-19 immunisation. Medical history included allergy unspecified from an unknown date. There were no concomitant medications. The patient previously took clonidine 0.1 mg, hydralazine 10 mg, cipro (ciprofloxacin) and sulfa for blood pressure abnormal and had itching. Patient also took spironolactone tablets for blood pressure abnormal and had a little rash of bumps under the skin on her right arm. On 01Feb2021, she received covid vaccine probably about 02:30. When she got home, about 2.5 hours later at 05:00, she started itching somewhat, a little redness at the left breast a little below the waistline, itching in the scalp and the right eye. There was nothing she could see in those places. She went ahead and called the pharmacist. The pharmacist told her to take Benadryl, so she took one 25 mg liquigel. It took the itch away. She went to bed and decided it had subsided. She decided to go ahead and take one more through for the night. When she woke up in the morning, she didn't have a problem. She was wondering if she should be concerned for the second shot. She didn't have a prescribing doctor. She got the invite to get it. It was gone through the night. Therapeutic measures were taken as a result of developing itchiness, a little redness at the left breast a little below the waistline, itching in the scalp and the right eye. Outcome of events was recovered on 02Feb2021.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 11:40 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 11:40 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 49.63.  Concomitant products were not provided.  On 15-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 06-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 09-May-2021. On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 PM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  Storage condition at the time of the excursion was reported as cooler storage during high-pace COVID-19 vaccination clinic. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
This pt was vaccinated with second dose of vax in fall of 1999. Post vax, the pt developed a rash 'up towards her shoulders, and shortly after developed pneumonia. A few months later, the pt developed pneumonia again and has been hospitalized for 12 days.' The pt's husband indicated that the hospital personnel 'think they have killed the infection.' In addition, he noted his wife has had a lot of chest X-rays. Additional information has been requested.   Follow-up information from a consumer indicated that "by 4/29/00 his wife developed an infection of undetermined origin." The consumer stated that his wife "did not have the type of pneumonia covered by the shots." No additional details were provided.
On 10/28: Paresthesias in 2 toes on left foot. On 10/29/11: Paresthesias in left hand and fingers progressing entire left arm and leg. Admitted to hospital on 10/29/11. On 10/30/11: Paresthesias in both arms and legs. On 10/31/11: Neuralgias. Hospital course was observational in nature. No specific treatments were administered.
This spontaneous report was received from a medical assistant and refers to an unknown number of patients of unspecified demographics. No information regarding the patients' medical histories, concomitant medication and drug reactions or allergies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA lot# N005274, expiration date: 03-APR-2018 (dose and route of administration were not reported). It was reported that the vaccines were exposed to the temperature range from 9 Celsius degrees to 25 Celsius degrees for a time frame of 2 hours 14 minutes. The temperature excursion was recorded by a digital data logger and there were no previous temperature excursions. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information is not expected since there was no consent for further contact. Sender's Comments: US-009507513-1705USA009556: US-009507513-1706USA003431: US-009507513-1706USA003432: US-009507513-1706USA003433.
feel a metallic taste on my tongue; my mouth is dry; when I start talking I produce a lot of saliva; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Jul2021 18:00 (Batch/Lot number: unknown) at the age of 42 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious) with onset 14Jul2021 10:00, outcome "not recovered", described as "feel a metallic taste on my tongue"; DRY MOUTH (non-serious) with onset 14Jul2021 10:00, outcome "not recovered", described as "my mouth is dry"; SALIVARY HYPERSECRETION (non-serious) with onset 14Jul2021 10:00, outcome "not recovered", described as "when I start talking I produce a lot of saliva". Therapeutic measures were not taken as a result of dysgeusia, dry mouth, salivary hypersecretion.  Additional information: Facility type vaccine was Hospital. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. Not covid tested post vaccination. No Known allergies. The next day, after the vaccination, she started to feel a metallic taste on her tongue. Even when she licked her lips it was as if the metallic taste was also in them. As long as she did not talk, her mouth was dry, but when she started talking she produced a lot of saliva. Other medical history was none.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 5/3/99 825AM & c/o eyes itching 835AM;stated did not get much sleep last noc;no SOB, cool cloth for eyes then c/o itching under arms & other parts of body;853AM c/o tongue tingling;856AM still itching & tongue numb;02 given